OrthoPediatrics corp (KIDS): Next-Year EPS Estimate 34.16%
As of 2026-11-06, OrthoPediatrics corp (KIDS) has a next-year EPS growth estimate of 34.16%. Featured in our EPS revision report on 2026-10-28.
On 2026-10-28, analyst consensus for KIDS's next-year EPS growth shifted from 35.61% to 34.16% — a negative change of 1.45 percentage points. The revised estimate has been sustained across 9 subsequent trading sessions. Current-year growth is projected at 28.74%.
What's Driving This
Analysts raised OrthoPediatrics’ next-year EPS growth estimate on 2026-10-19 from 32.20% to 35.61%, a 3.41 percentage-point increase that supports the earnings outlook. No recent headlines are available to identify a specific catalyst such as an earnings beat, contract win, guidance raise, or product launch. The current next
Generated 2026-10-28 from news as of 2026-10-28
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 34.16%
- EPS growth this year
- 28.74%
- EPS next quarter (est)
- -$0.21
- Last price
- $32.22
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-06 | 34.16% | 28.74% | -$0.21 | $32.22 |
| 2026-11-05 | 34.16% | 28.74% | -$0.21 | $32.22 |
| 2026-11-04 | 34.16% | 28.74% | -$0.21 | $33.51 |
| 2026-11-03 | 34.16% | 28.74% | -$0.21 | $31.41 |
| 2026-11-02 | 34.16% | 28.74% | -$0.21 | $30.43 |
| 2026-10-31 | 34.16% | 28.74% | -$0.21 | $30.87 |
| 2026-10-30 | 34.16% | 28.74% | -$0.21 | $30.87 |
| 2026-10-29 | 34.16% | 28.74% | -$0.21 | $31.52 |
| 2026-10-28 | 34.16% | 28.74% | -$0.21 | $30.80 |
| 2026-10-27 | 35.61% | 29.50% | -$0.24 | $23.82 |
| 2026-10-26 | 35.61% | 29.50% | -$0.21 | $24.02 |
| 2026-10-23 | 35.61% | 29.50% | -$0.21 | $24.50 |
| 2026-10-22 | 35.61% | 29.50% | -$0.21 | $24.71 |
| 2026-10-21 | 35.61% | 29.50% | -$0.21 | $23.84 |
| 2026-10-20 | 35.61% | 29.50% | -$0.21 | $23.50 |
| 2026-10-19 | 35.61% | 29.50% | -$0.21 | $22.03 |
| 2026-10-16 | 32.20% | 28.11% | -$0.23 | $21.95 |
| 2026-10-15 | 32.20% | 28.11% | -$0.23 | $22.57 |
| 2026-10-14 | 32.20% | 28.11% | -$0.23 | $22.25 |
| 2026-10-13 | 32.69% | 27.59% | -$0.23 | $21.93 |
| 2026-10-12 | 32.69% | 27.59% | -$0.23 | $22.08 |
| 2026-10-11 | 32.69% | 27.59% | -$0.23 | $21.65 |
| 2026-10-10 | 32.69% | 27.59% | -$0.23 | $21.65 |
| 2026-10-09 | 32.69% | 27.59% | -$0.23 | $21.65 |
| 2026-10-08 | 32.69% | 27.59% | -$0.23 | $21.76 |
| 2026-10-07 | 32.69% | 27.59% | -$0.23 | $22.48 |
| 2026-10-06 | 32.69% | 27.59% | -$0.23 | $22.71 |
| 2026-10-05 | 32.69% | 27.59% | -$0.23 | $22.89 |
| 2026-10-04 | 32.69% | 27.59% | -$0.23 | $22.16 |
| 2026-10-03 | 32.69% | 27.59% | -$0.23 | $22.16 |
Reports Featuring KIDS
Screen Performance
Aggregate stats across all 2130 tickers our top-EPS-revision screen has flagged over the past 219 days.
- Median return since detection
- -3.9%
- % of tickers in the green
- 41%
- Median return on winners
- +23.3%
- Large revisions captured
- 2083
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is OrthoPediatrics corp's next-year EPS growth estimate?▾
As of 2026-11-06, OrthoPediatrics corp (KIDS) has a next-year EPS growth estimate of 34.16%, based on analyst consensus.
When was the latest EPS estimate revision for KIDS?▾
The most recent revision occurred on 2026-10-28, when analysts adjusted the next-year EPS growth estimate from 35.61% to 34.16%.
What sector and industry does OrthoPediatrics corp belong to?▾
OrthoPediatrics corp operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KIDS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. OrthoPediatrics corp (KIDS) appears here because it was detected by our daily top-EPS-revision-performer screen.